Literature DB >> 32227198

Optimizing the Trade-off Between Learning and Doing in a Pandemic.

Derek C Angus1,2.   

Abstract

Year:  2020        PMID： 32227198     DOI： 10.1001/jama.2020.4984

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  44 in total

1.  Participation of more community hospitals in randomized trials of treatments for COVID-19 is needed.

Authors:  Jennifer L Y Tsang; Alexandra Binnie; George Farjou; Dimitra Fleming; Maham Khalid; Erick Duan
Journal:  CMAJ       Date:  2020-05-19       Impact factor: 8.262

2.  Perioperative planning in the COVID-19 pandemic: Cardiovascular perfusion and device-related issues.

Authors:  Serdar Günaydın
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

3.  Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

Authors:  Olivier Hermine; Xavier Mariette; Pierre-Louis Tharaux; Matthieu Resche-Rigon; Raphaël Porcher; Philippe Ravaud
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873

4.  Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors:  Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

5.  Beyond Causality: Additional Benefits of Randomized Controlled Trials for Improving Health Care Delivery.

Authors:  Marcella Alsan; Amy N Finkelstein
Journal:  Milbank Q       Date:  2021-07-20       Impact factor: 4.911

6.  Sepsis Subclasses: A Framework for Development and Interpretation.

Authors:  Kimberley M DeMerle; Derek C Angus; J Kenneth Baillie; Emily Brant; Carolyn S Calfee; Joseph Carcillo; Chung-Chou H Chang; Robert Dickson; Idris Evans; Anthony C Gordon; Jason Kennedy; Julian C Knight; Christopher J Lindsell; Vincent Liu; John C Marshall; Adrienne G Randolph; Brendon P Scicluna; Manu Shankar-Hari; Nathan I Shapiro; Timothy E Sweeney; Victor B Talisa; Benjamin Tang; B Taylor Thompson; Ephraim L Tsalik; Tom van der Poll; Lonneke A van Vught; Hector R Wong; Sachin Yende; Huiying Zhao; Christopher W Seymour
Journal:  Crit Care Med       Date:  2021-05-01       Impact factor: 7.598

Review 7.  COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

Authors:  Eddy Fan; Jeremy R Beitler; Laurent Brochard; Carolyn S Calfee; Niall D Ferguson; Arthur S Slutsky; Daniel Brodie
Journal:  Lancet Respir Med       Date:  2020-07-06       Impact factor: 30.700

8.  Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.

Authors:  Geert Byttebier; Luc Belmans; Myriam Alexander; Bo E H Saxberg; Bart De Spiegeleer; Anton De Spiegeleer; Nick Devreker; Jens T Van Praet; Karolien Vanhove; Reinhilde Reybrouck; Evelien Wynendaele; David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2021-05-28       Impact factor: 3.452

9.  Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk.

Authors:  Gail Hayward; Christopher C Butler; Ly-Mee Yu; Benjamin R Saville; Nicholas Berry; Jienchi Dorward; Oghenekome Gbinigie; Oliver van Hecke; Emma Ogburn; Hannah Swayze; Emily Bongard; Julie Allen; Sharon Tonner; Heather Rutter; Sarah Tonkin-Crine; Aleksandra Borek; David Judge; Jenna Grabey; Simon de Lusignan; Nicholas P B Thomas; Philip H Evans; Monique I Andersson; Martin Llewelyn; Mahendra Patel; Susan Hopkins; F D Richard Hobbs
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692

10.  Precision medicine for COVID-19: a call for better clinical trials.

Authors:  Gentle Sunder Shrestha; Hem Raj Paneru; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-02       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.